NERV Minerva Operating Profitability

Minerva Neurosciences (NERV) - corporate logo

The operating margin of Minerva Neurosciences (NERV) reflects a specific model where the development of antipsychotic drugs relies on external contractors (CRO/CMO). The absence of recurring revenue makes financial stability hostage to trial outcomes, and 0.00 shows the current value of this metric. Meanwhile, a compact staff of CNS experts is retained through stock options, minimizing the risk of losing key competencies.

Minerva Neurosciences, Inc. (NERV): Operating Return on Sales from 07/04/2022 to 11/19/2026

Analytical breakdowns for Minerva Neurosciences

Initial company analysis:minervaneurosciences.com, NERV
Finished products of Minerva

The development of roluperidone for schizophrenia therapy by Minerva Neurosciences (NERV) requires significant expenditures, making the tracking of operating margins essential for assessing resource management efficiency while capturing an open market niche. This indicator is calculated as the ratio of operating profit to revenue, measuring the business's ability to generate income before taxes and interest, which determines the asset's fundamental value in the eyes of investors.

Competitors of Minerva Neurosciences

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|OMER (Omeros Corp) - Operating Margin|Operating Margin neurogene.com|Operating Margin ACIU|VYGR - Operating Return on Sales|Operating Profitability Neumora Therapeutics Inc NMRA|Profitability of Operations Scilex Holding Co. (SCLX)|TVGN - Operating Profitability|Operating Return on Sales alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Operating Sales Margin|IKT: Operating Profit Ratio|Operating Profitability Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operating Profit Ratio|Operating Profitability Coya (COYA)|VTGN - Operating Return on Sales|Operating Margin OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Operating Return on Sales|cervomed.com - Operating Margin|Operating Profit Rate ATHE (Alterity Therapeutics Limited)|CLNN: Operating Margin|Operating Sales Margin PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operating Margin|Operating Return on Sales Relmada Therapeutics Inc RLMD|Operating Profitability Annovis Bio Corporation (ANVS)|GRCE - Operating Return on Sales|Operating Profitability Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Operating Return on Sales|NeuroSense Therapeutics, Ltd. - Operating Margin|RVPH: Operating Profitability|MTVA: Operating Margin|NRXS - Profitability of Operations|HSDT (Helius Medical Technologies Inc.) - Operating Margin|Operating Return on Sales Passage Bio PASG|Operating Profitability Neuphoria (NEUP)|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin